Evidence map›Paper›PMID 31640297›Full record

ReviewCancers2019

Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis.

Mohamed A Abd El Aziz, Komal Agarwal, Subramanyam Dasari, And Anirban K Mitra

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mohamed A Abd El AzizMedical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405, USA. mohamad102365@fmed.bu.edu.eg.
Komal AgarwalMedical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405, USA. komalbasani@gmail.com.
Subramanyam DasariMedical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405, USA. sudasari@iu.edu.
And Anirban K MitraMedical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405, USA. anmitra@indiana.edu.
Indiana University Bloomington · USIndiana University Health · US

Funding

U.S. Department of Defense W81XWH-15-0253
6 · The paper itself

Abstract

Most ovarian cancer patients present with disseminated disease at the time of their diagnosis, which is one of the main reasons for their poor prognosis. Metastasis is a multi-step process and a clear understanding of the mechanism of regulation of these steps remains elusive. Productive reciprocal interactions between the metastasizing ovarian cancer cells and the microenvironment of the metastatic site or the tumor microenvironment play an important role in the successful establishment of metastasis. Much progress has been made in the recent past in our understanding of such interactions and the role of the cellular and acellular components of the microenvironment in establishing the metastatic tumors. This review will outline the role of the microenvironmental components of the ovarian cancer metastatic niche and their role in helping establish the metastatic tumors. Special emphasis will be given to the mesothelial cells, which are the first cells encountered by the cancer cells at the site of metastasis.

Indexed as

adipocytescross-talkECMfibroblastsmesothelial cellsmetastasismicroenvironmentOvarian cancer

Identifiers

PMID31640297
PMCPMC6827352
OpenAlexW2980606387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.